9
91maker
AcceleratorModerate91maker is an incubator focused on laboratory technology incubation.
6
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for 91maker.
Investment Thesis & Strategy
91maker, as an accelerator, invests in various stages of fintech and venture capital companies, specifically focusing on laboratory technology incubation. They look for early-stage companies with innovative solutions in the laboratory technology space.
Investment Activity
Deals per year over the last 6 years
1
20170
20183
20190
20207
20211
2022Portfolio Companies
Selected investments from their portfolio of 6 companies
E
Enveda Biosciences
Biotech · Series B, 2022
C
Cellino
Biotech · Series A, 2021
G
Generate Biomedicines
Biotech · Series B, 2021
E
Eikon Therapeutics
Biotech · Series B, 2021
D
Deepcell
Biotech · Series A, 2021
B
Bit.bio
Biotech · Series B, 2021
L
Laronde
Biotech · Series B, 2021
T
Tessera Therapeutics
Biotech · Series B, 2021
V
Verge Genomics
Biotech · Series A, 2019
S
Sana Biotechnology
Biotech · Series B, 2019
B
BioAge Labs
Biotech · Series B, 2019
F
Finch Therapeutics
Biotech · Series B, 2017
Frequently Asked Questions
91maker focuses on Pre-seed, Seed stage investments.